In a recent population-based study within two university cities in Sweden, we demonstrated that measurement of survivin individually or in combination with RA-specific antibodies improves estimation of RA risk and prospectively predicts RA development in patients with arthralgia (53). This evidence concerns the gene BIRC5 and rheumatoid arthritis.